Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 122.50
-2.00 (-1.61%)
Jan 13, 2026, 10:05 AM CST
Grape King Bio Market Cap
Grape King Bio has a market cap or net worth of 18.44 billion as of January 12, 2026. Its market cap has decreased by -17.82% in one year.
Market Cap
18.44B
Enterprise Value
16.90B
Revenue
10.40B
Ranking
n/a
PE Ratio
15.20
Stock Price
122.50
Market Cap Chart
Since February 19, 1992, Grape King Bio's market cap has increased from 2.32B to 18.44B, an increase of 694.09%. That is a compound annual growth rate of 6.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 18.44B | -1.58% |
| Dec 31, 2025 | 18.74B | -15.38% |
| Dec 31, 2024 | 22.15B | -4.17% |
| Dec 29, 2023 | 23.11B | -7.14% |
| Dec 30, 2022 | 24.89B | 5.00% |
| Dec 30, 2021 | 23.70B | -2.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 228.62B |
| PharmaEssentia | 189.36B |
| Lotus Pharmaceutical | 76.92B |
| Bora Pharmaceuticals Co., LTD. | 64.12B |
| Heron Neutron Medical | 59.70B |
| Oneness Biotech | 33.15B |
| Lumosa Therapeutics | 31.67B |
| Center Laboratories | 30.53B |